Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers
Recombinant vesicular stomatitis virus (VSV)-fusion and hemagglutinin (FH) was developed by substituting the promiscuous VSV-G glycoprotein (G) gene in the backbone of VSV with genes encoding for the measles virus envelope proteins F and H. Hybrid VSV-FH exhibited a multifaceted mechanism of cancer-...
Main Authors: | Bolni Marius Nagalo, Camilo Ayala Breton, Yumei Zhou, Mansi Arora, James M. Bogenberger, Oumar Barro, Michael B. Steele, Nathan J. Jenks, Alexander T. Baker, Dan G. Duda, Lewis Rowland Roberts, Stephen J. Russell, Kah Whye Peng, Mitesh J. Borad |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Molecular Therapy: Oncolytics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2372770520301248 |
Similar Items
-
Mechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapy
by: Simovic B, et al.
Published: (2015-10-01) -
Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants
by: Lisa Pipperger, et al.
Published: (2021-01-01) -
Collateral Lethal Effects of Complementary Oncolytic Viruses
by: Justin W. Maroun, et al.
Published: (2020-09-01) -
Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions
by: Molly C. Holbrook, et al.
Published: (2021-03-01) -
Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a “Hammer” and “Anvil”
by: Michael Karl Melzer, et al.
Published: (2017-02-01)